Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analytical Performance of the NCI-myeloMATCH Assay: A Rapid Turnaround Genomic Profiling Assay for Myeloid Disorders.

The Journal of molecular diagnostics : JMD - 1 Aug 2025

Yeung Cecilia C S, Narava Srikrishna K, Chang Ting-Chia, Saeed Maria, Aicher Lauri, Beppu Lan W, Majano Marvin S, Taylor Erin M, Camalier Corinne E, Sandhuria Pooja, Sala-Torra Olga, Li Jessica, Yee Laura M, McShane Lisa M, Karlovich Chris, Little Richard F, Harris Lyndsay, Doroshow James H, Williams Paul M, Radich Jerald P, Jiwani Shahanawaz

Abstract excerpt

myeloMATCH is a National Cancer Institute (NCI) precision medicine clinical trial initiative to evaluate treatments for acute myeloid leukemia and myelodysplastic syndrome based on a leukemia's diagnostic molecular-genetic profile. The NCI myeloid assay version 2 (NMAv2) uses the Genexus System, an automated platform with <48-hour turnaround from specimen receipt to reporting, to provide harmonized...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomics
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to Myelodysplastic Syndromes

Share to Precision Medicine

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 40381914
DOI: 10.1016/j.jmoldx.2025.05.001
PMCID: PMC12405911

Genes

FLT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analytical Performance of the NCI-myeloMATCH Assay: A Rapid Turnaround Genomic Profiling Assay for Myeloid Disorders.PMID 40381914Read ↗

Analytical Validation of an Automated Semiconductor-Based Next-Generation Sequencing Assay for Detection of DNA and RNA Alterations in Myeloid Neoplasms.Semantic proximity Read ↗

Clinical Validation of a Myeloid Next-Generation Sequencing Panel for Single-Nucleotide Variants, Insertions/Deletions, and Fusion Genes.Semantic proximity Read ↗

Clinical validation of the Ion Torrent Oncomine Myeloid Assay GX v2 on the Genexus Integrated Sequencer as a stand-alone assay for single-nucleotide variants, insertions/deletions, and fusion genes: Challenges, performance, and perspectives.Semantic proximity Read ↗

Comprehensive Validation of Diagnostic Next-Generation Sequencing Panels for Acute Myeloid Leukemia Patients.Semantic proximity Read ↗

Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture-Based Gene Panel.Semantic proximity Read ↗

Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies.Semantic proximity Read ↗

Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting.Semantic proximity Read ↗

Genomics of Acute Myeloid Leukemia at Diagnosis and RemissionSemantic proximity Read ↗

Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies.Semantic proximity Read ↗

Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.Semantic proximity Read ↗

Analytical Validation of a 37-Gene Next-Generation Sequencing Panel for Myeloid Malignancies and Review of Initial Findings Incorporating Updated 2022 Diagnostic and Prognostic Guidelines.Semantic proximity Read ↗

Rapid and Automated Semiconductor-Based Next-Generation Sequencing for Simultaneous Detection of Somatic DNA and RNA Aberrations in Myeloid Neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.